Literature DB >> 27407815

Sarcoidosis following Chemotherapy of Essential Thrombocythemia with Hydroxyurea.

Mps Sawhney1, D K Mishra2.   

Abstract

Entities:  

Keywords:  Essential thrombocythemia; Sarcoidosis

Year:  2011        PMID： 27407815      PMCID： PMC4922953          DOI： 10.1016/S0377-1237(05)80074-7

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  10 in total

1.  Cutaneous sarcoid reactions during long-term remission in a patient with acute myelogenous leukemia.

Authors:  M Isoda
Journal:  J Dermatol       Date:  1996-04       Impact factor: 4.005

2.  Association between chronic lymphocytic leukemia and sarcoidosis: clinical value of bronchoalveolar lavage.

Authors:  A Marruchella; R Epis; G Camerone; M Tondini
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1999-03       Impact factor: 0.670

3.  Interferon-alpha therapy associated with the development of sarcoidosis.

Authors:  A Pietropaoli; J Modrak; M Utell
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

4.  Pulmonary sarcoidosis in a patient with essential thrombocythemia treated with interferon alpha: a short case report.

Authors:  H Franková; A Gaja; N Hejlová
Journal:  Med Sci Monit       Date:  2000 Mar-Apr

Review 5.  Contemporaneous acute myeloid leukaemia and sarcoidosis. Report of three cases.

Authors:  L Pagano; G Visani; F Ferrara; A Cenacchi; A Bonini; F Equitani; L Fuso; R Piscitelli; G Pagliari
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1998-03       Impact factor: 0.670

6.  MalignancyCase Report: Systemic Sarcoidosis Preceeding Acute Myeloid Leukemia.

Authors:  CAROL Alliot; MARTA Barrios; FRÉDÉRIC Franck
Journal:  Hematology       Date:  2000       Impact factor: 2.269

7.  Association between sarcoidosis and lymphoma revisited.

Authors:  M Karakantza; E Matutes; K MacLennan; N T O'Connor; P C Srivastava; D Catovsky
Journal:  J Clin Pathol       Date:  1996-03       Impact factor: 3.411

Review 8.  [Malignancies in patients with sarcoidosis].

Authors:  M Kataoka; Y Nakata; T Hioka; S Hosoya; K Shiomi; H Nishizaki; R Morishita; Y Ono; T Ohnoshi; I Kimura
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1992-04

9.  Sarcoidosis induced by interferon therapy for chronic myelogenous leukaemia.

Authors:  M Kikawada; Y Ichinose; A Kunisawa; N Yanagisawa; K Minemura; I Kasuga; M Yonemaru; K Kawanishi; M Takasaki; K Toyama
Journal:  Respirology       Date:  1998-03       Impact factor: 6.424

Review 10.  Granulomatous bone marrow disease. A review of the literature and clinicopathologic analysis of 58 cases.

Authors:  C R Bodem; B H Hamory; H M Taylor; L Kleopfer
Journal:  Medicine (Baltimore)       Date:  1983-11       Impact factor: 1.889
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.